Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrijono

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Oman Medical Journal|May 22, 2019
Role of Cancer Stem Cell, Apoptotic Factor, DNA Repair, and Telomerase Toward Radiation Therapy Response in Stage IIIB Cervical CancerLisnawati Rachmadi, Nurjati Chairani Siregar, Mpu Kanoko, et al.
Journal of Obstetrics and Gynaecology of India|July 8, 2024
Cancer Stem Cells (CD44<sup>+</sup>/CD24<sup>-</sup>), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer ChemoresistanceUnedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, et al.
Journal of Obstetrics and Gynaecology of India|May 20, 2025
Correction: Cancer Stem Cells (CD44<sup>+</sup>/CD24<sup>-</sup>), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer ChemoresistanceUnedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, et al.
Journal of the Egyptian National Cancer Institute|October 24, 2022
CD44<sup>+</sup>/CD24<sup>-</sup> Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry studyUnedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, et al.
The Malaysian Journal of Medical Sciences : MJMS|March 28, 2019
SEMA3B but Not CUL1 as Marker for Pre-Eclampsia ProgressionTjam Diana Samara, Isabella Kurnia Liem, Ani Retno Prijanti, et al.
Polish Journal of Radiology|July 3, 2020
Minimal apparent diffusion coefficient value of the solid component to differentiate borderline and malignant ovarian epithelial tumours: a preliminary reportSahat B R E Matondang, Avrilia Ekawati, Andrijono, et al.
Journal of Radiology Case Reports|May 5, 2023
Diagnostic Challenge: Distinguishing Uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case ReportHariyono Winarto, Octaviyana Nadia Nitasari Simatupang, David Calvin, et al.
Journal of Clinical Medicine|March 17, 2025
A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020Primariadewi Rustamadji, Elvan Wiyarta, Kartiwa Hadi Nuryanto, et al.
Journal of Human Reproductive Sciences|August 15, 2020
CYP19A1 Gene Expression in Patients with Polycystic Ovarian SyndromeRoselina Panghiyangani, Purnomo Soeharso, Andrijono, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 23, 2020
Biocurcumin as Radiosensitiser for Cervical Cancer Study (BRACES): A Double-Blind Randomised Placebo-Controlled TrialSigit Purbadi, Primariadewi Rustamadji, Ani R Prijanti, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Oman Medical Journal|May 22, 2019
Role of Cancer Stem Cell, Apoptotic Factor, DNA Repair, and Telomerase Toward Radiation Therapy Response in Stage IIIB Cervical CancerLisnawati Rachmadi, Nurjati Chairani Siregar, Mpu Kanoko, et al.
Journal of Obstetrics and Gynaecology of India|July 8, 2024
Cancer Stem Cells (CD44<sup>+</sup>/CD24<sup>-</sup>), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer ChemoresistanceUnedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, et al.
Journal of Obstetrics and Gynaecology of India|May 20, 2025
Correction: Cancer Stem Cells (CD44<sup>+</sup>/CD24<sup>-</sup>), RAD6, DDB2 Immunohistochemistry Expression and IHC-UNEDO Scoring System As Predictor of Ovarian Cancer ChemoresistanceUnedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, et al.
Journal of the Egyptian National Cancer Institute|October 24, 2022
CD44<sup>+</sup>/CD24<sup>-</sup> Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry studyUnedo Hence Markus Sihombing, Andrijono Andrijono, Gatot Purwoto, et al.
The Malaysian Journal of Medical Sciences : MJMS|March 28, 2019
SEMA3B but Not CUL1 as Marker for Pre-Eclampsia ProgressionTjam Diana Samara, Isabella Kurnia Liem, Ani Retno Prijanti, et al.
Polish Journal of Radiology|July 3, 2020
Minimal apparent diffusion coefficient value of the solid component to differentiate borderline and malignant ovarian epithelial tumours: a preliminary reportSahat B R E Matondang, Avrilia Ekawati, Andrijono, et al.
Journal of Radiology Case Reports|May 5, 2023
Diagnostic Challenge: Distinguishing Uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case ReportHariyono Winarto, Octaviyana Nadia Nitasari Simatupang, David Calvin, et al.
Journal of Clinical Medicine|March 17, 2025
A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020Primariadewi Rustamadji, Elvan Wiyarta, Kartiwa Hadi Nuryanto, et al.
Journal of Human Reproductive Sciences|August 15, 2020
CYP19A1 Gene Expression in Patients with Polycystic Ovarian SyndromeRoselina Panghiyangani, Purnomo Soeharso, Andrijono, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 23, 2020
Biocurcumin as Radiosensitiser for Cervical Cancer Study (BRACES): A Double-Blind Randomised Placebo-Controlled TrialSigit Purbadi, Primariadewi Rustamadji, Ani R Prijanti, et al.
Pageof 3